Gemmer Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-442
| Closed | -$230K | – | 157 |
|
|
2024
Q3 | $230K | Hold |
442
| – | – | 0.02% | 139 |
|
|
2024
Q2 | $240K | Hold |
442
| – | – | 0.03% | 124 |
|
|
2024
Q1 | $229K | Hold |
442
| – | – | 0.03% | 123 |
|
|
2023
Q4 | $208K | Buy |
+442
| New | +$204K | 0.03% | 126 |
|
|
2023
Q2 | – | Sell |
-442
| Closed | -$203K | – | 127 |
|
|
2023
Q1 | $203K | Hold |
442
| – | – | 0.03% | 121 |
|
|
2022
Q4 | $227K | Buy |
+442
| New | +$224K | 0.04% | 107 |
|
|
2022
Q2 | – | Sell |
-242
| Closed | -$118K | – | 400 |
|
|
2022
Q1 | $118K | Hold |
242
| – | – | 0.01% | 155 |
|
|
2021
Q4 | $112K | Hold |
242
| – | – | 0.01% | 169 |
|
|
2021
Q3 | $90K | Hold |
242
| – | – | 0.01% | 169 |
|
|
2021
Q2 | $92K | Buy |
242
+4
| +2% | +$1.53K | 0.01% | 182 |
|
|
2021
Q1 | $85K | Hold |
238
| – | – | 0.01% | 177 |
|
|
2020
Q4 | $76K | Hold |
238
| – | – | 0.01% | 172 |
|
|
2020
Q3 | $64K | Sell |
238
-89
| -27% | -$23.9K | 0.01% | 175 |
|
|
2020
Q2 | $86K | Hold |
327
| – | – | 0.02% | 140 |
|
|
2020
Q1 | $74K | Buy |
327
+89
| +37% | +$24.3K | 0.02% | 134 |
|
|
2019
Q4 | $72K | Sell |
238
-1
| -0.4% | -$275 | 0.02% | 158 |
|
|
2019
Q3 | $57K | Sell |
239
-66
| -22% | -$18.1K | 0.01% | 180 |
|
|
2019
Q2 | $86K | Hold |
305
| – | – | 0.02% | 131 |
|
|
2019
Q1 | $88K | Sell |
305
-16
| -5% | -$4.63K | 0.02% | 132 |
|
|
2018
Q4 | $84K | Hold |
321
| – | – | 0.03% | 128 |
|
|
2018
Q3 | $88K | Sell |
321
-43
| -12% | -$11.2K | 0.03% | 127 |
|
|
2018
Q2 | $87K | Hold |
364
| – | – | 0.03% | 128 |
|
|
2018
Q1 | $80K | Hold |
364
| – | – | 0.03% | 131 |
|
|
2017
Q4 | $82K | Hold |
364
| – | – | 0.03% | 137 |
|
|
2017
Q3 | $69K | Hold |
364
| – | – | 0.03% | 145 |
|
|
2017
Q2 | $68K | Hold |
364
| – | – | 0.03% | 146 |
|
|
2017
Q1 | $60K | Hold |
364
| – | – | 0.03% | 155 |
|
|
2016
Q4 | $52K | Hold |
364
| – | – | 0.03% | 161 |
|
|
2016
Q3 | $46K | Hold |
364
| – | – | 0.02% | 176 |
|
|
2016
Q2 | $48K | Hold |
364
| – | – | 0.03% | 165 |
|
|
2016
Q1 | $50K | Hold |
364
| – | – | 0.03% | 161 |
|
|
2015
Q4 | $51K | Hold |
364
| – | – | 0.03% | 158 |
|
|
2015
Q3 | $51K | Hold |
364
| – | – | 0.03% | 169 |
|
|
2015
Q2 | $60K | Hold |
364
| – | – | 0.04% | 157 |
|
|
2015
Q1 | $56K | Hold |
364
| – | – | 0.03% | 166 |
|
|
2014
Q4 | $46K | Hold |
364
| – | – | 0.03% | 180 |
|
|
2014
Q3 | $44K | Hold |
364
| – | – | 0.03% | 182 |
|
|
2014
Q2 | $39K | Hold |
364
| – | – | 0.03% | 192 |
|
|
2014
Q1 | $36K | Buy |
+364
| New | +$32.9K | 0.03% | 200 |
|
Other funds holding ELV
Gemmer Asset Management's ELV Position: Q4 2024 in Review
Gemmer Asset Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 442 shares — an estimated $230K sold.
Gemmer Asset Management first reported a position in ELV in Q1 2014 and held it in 39 quarters. The position peaked at $240K in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q4 2024.
- Gemmer Asset Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
- Gemmer Asset Management sold 442 Elevance Health shares in Q4 2024, an estimated $230K.
- Gemmer Asset Management first reported a position in Elevance Health in Q1 2014 and held it in 39 quarters.
- Gemmer Asset Management's Elevance Health position peaked at $240K in Q2 2024.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.
Based on Gemmer Asset Management's 13F filing for Q4 2024, filed 16 Jan 2025.